Lung Adenosquamous Carcinoma

specific

An aggressive carcinoma with a poor prognosis characterized by a presence of both malignant squamous cells and glandular cells.

34

Centers

12

Active Trials

Cancer Funding

Top Centers for Lung Adenosquamous Carcinoma(34)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
Active Research Program
66.0
2
NCI Comprehensive
Active Research Program
66.0
3
NCI Comprehensive
Active Research Program
66.0
4
NCI Comprehensive
Active Research Program
66.0
5
NCI Comprehensive
Active Research Program
66.0
6
NCI Comprehensive
Active Research Program
66.0
7
Active Research Program
66.0
8
Active Research Program
66.0
9
Active Research Program
66.0
10
NCI Comprehensive
Active Research Program
66.0
11
Active Research Program
66.0
12
Active Research Program
66.0
13
NCI Comprehensive
43.5
14
NCI Comprehensive
43.5
15
NCI Comprehensive
43.5
16
NCI Comprehensive
43.5
1743.5
1843.5
19
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
43.5
2043.5
21
NCI Comprehensive
43.5
22
NCI Comprehensive
43.5
2343.5
24
NCI Comprehensive
43.5
25
NCI Comprehensive
43.5
26
NCI Comprehensive
43.5
2743.5
28
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
43.5
2943.5
3043.5
3143.5
3243.5
3343.5
3443.5

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →